摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-phenylmethylene-naphtho[2,1-b]furan-1(2H)-one | 88503-21-3

中文名称
——
中文别名
——
英文名称
2-phenylmethylene-naphtho[2,1-b]furan-1(2H)-one
英文别名
2-benzylidene-naphtho[2,1-b]furan-1-one;2-Benzyliden-naphtho[2,1-b]furan-1-on;2-Benzylidenenaphtho[2,1-b]furan-1(2H)-one;2-benzylidenebenzo[e][1]benzofuran-1-one
2-phenylmethylene-naphtho[2,1-b]furan-1(2H)-one化学式
CAS
88503-21-3
化学式
C19H12O2
mdl
——
分子量
272.303
InChiKey
KVTOUJXIEXWYOA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-phenylmethylene-naphtho[2,1-b]furan-1(2H)-one 在 palladium 10% on activated carbon 、 氢气 作用下, 以 1,4-二氧六环甲醇 为溶剂, 以1.3 g的产率得到2-benzylnaphtho[2,1-b]furan-1(2H)-one
    参考文献:
    名称:
    钯催化脱羧脱芳基不对称烯丙基烷基化的光学活性黄酮类分子
    摘要:
    借助一类新发现的带有手性环烷烃骨架的 Trost 型双膦配体,Pd 催化的苯并呋喃脱羧脱芳基不对称烯丙基烷基化 (AAA) 高效 [0.2-1.0 mol% Pd2(dba)3 /L],良好的通用性和高对映选择性(> 30 个实例,82-99% 产率和 90-96% ee)。此外,公开了以前无法到达的黄酮类化合物的面向多样性的合成(DOS)。它具有可靠且可扩展的新开发的 Tsuji-Trost-Stoltz AAA 序列、Wacker-Grubbs-Stoltz 氧化、安息香内缩合和共轭加成,可有效构建具有挑战性的紧凑型具有连续立体中心的环戊二烯[b]苯并呋喃支架。该策略为开发基于黄格兰的药物提供了新途径。
    DOI:
    10.1021/jacs.0c05113
  • 作为产物:
    描述:
    1-(2-tert-butyldimethylsilyloxynaphthalen-1-yl)-3-phenyl-2-propyn-1-one 在 四丁基氟化铵 作用下, 以72%的产率得到2-phenylmethylene-naphtho[2,1-b]furan-1(2H)-one
    参考文献:
    名称:
    β-Naphthoflavone analogs as potent and soluble aryl hydrocarbon receptor agonists: Improvement of solubility by disruption of molecular planarity
    摘要:
    The physiological role of aryl hydrocarbon receptor (AhR) is not yet fully understood, and investigation is hampered by the limited solubility of reported AhR ligands in aqueous media. To achieve improved solubility, we focused on our previous finding that planarity-disruption of molecules leads to less efficient crystal packing and greater aqueous solubility. Here, we describe chemical modification of an AhR agonist, beta-naphthoflavone, focusing on planarity-disruption. As expected, introduction of substituents at the ortho-positions of the phenyl group resulted in greater solubility. Among the compounds prepared, the fluoro analog showed more potent AhR agonistic activity and greater solubility than did b-naphthoflavone. Our results indicate that this strategy to improve aqueous solubility, that is, introduction of substituent(s) that disrupt planarity, may be generally applicable to bicyclic molecules. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.12.036
点击查看最新优质反应信息

文献信息

  • Ingham et al., Journal of the Chemical Society, 1931, p. 895,900
    作者:Ingham et al.
    DOI:——
    日期:——
  • Blaser, Jahrb. philos. Fakultaet II Univ. Bern 2 <1922>, 48
    作者:Blaser
    DOI:——
    日期:——
  • Optically Active Flavaglines-Inspired Molecules by a Palladium-Catalyzed Decarboxylative Dearomative Asymmetric Allylic Alkylation
    作者:Meng-Yue Cao、Bin-Jie Ma、Zhi-Qi Lao、Hongliang Wang、Jing Wang、Juan Liu、Kuan Xing、Yu-Hao Huang、Kang-Ji Gan、Wei Gao、Huaimin Wang、Xin Hong、Hai-Hua Lu
    DOI:10.1021/jacs.0c05113
    日期:2020.7.15
    With the aid of a class of newly discovered Trost-type bisphosphine ligands bearing a chiral cycloalkane framework, the Pd-catalyzed decarboxylative dearomative asymmetric allylic alkylation (AAA) of benzofurans was achieved with high efficiency [0.2-1.0 mol% Pd2(dba)3/L], good generality and high enantioselectivity (> 30 examples, 82-99% yield and 90-96% ee). Moreover, a diversity-oriented synthesis
    借助一类新发现的带有手性环烷烃骨架的 Trost 型双膦配体,Pd 催化的苯并呋喃脱羧脱芳基不对称烯丙基烷基化 (AAA) 高效 [0.2-1.0 mol% Pd2(dba)3 /L],良好的通用性和高对映选择性(> 30 个实例,82-99% 产率和 90-96% ee)。此外,公开了以前无法到达的黄酮类化合物的面向多样性的合成(DOS)。它具有可靠且可扩展的新开发的 Tsuji-Trost-Stoltz AAA 序列、Wacker-Grubbs-Stoltz 氧化、安息香内缩合和共轭加成,可有效构建具有挑战性的紧凑型具有连续立体中心的环戊二烯[b]苯并呋喃支架。该策略为开发基于黄格兰的药物提供了新途径。
  • β-Naphthoflavone analogs as potent and soluble aryl hydrocarbon receptor agonists: Improvement of solubility by disruption of molecular planarity
    作者:Yuji Fujita、Mitsuhiro Yonehara、Masashi Tetsuhashi、Tomomi Noguchi-Yachide、Yuichi Hashimoto、Minoru Ishikawa
    DOI:10.1016/j.bmc.2009.12.036
    日期:2010.2
    The physiological role of aryl hydrocarbon receptor (AhR) is not yet fully understood, and investigation is hampered by the limited solubility of reported AhR ligands in aqueous media. To achieve improved solubility, we focused on our previous finding that planarity-disruption of molecules leads to less efficient crystal packing and greater aqueous solubility. Here, we describe chemical modification of an AhR agonist, beta-naphthoflavone, focusing on planarity-disruption. As expected, introduction of substituents at the ortho-positions of the phenyl group resulted in greater solubility. Among the compounds prepared, the fluoro analog showed more potent AhR agonistic activity and greater solubility than did b-naphthoflavone. Our results indicate that this strategy to improve aqueous solubility, that is, introduction of substituent(s) that disrupt planarity, may be generally applicable to bicyclic molecules. (C) 2010 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

降钙素 金色草素 苦杏碱醇B 海生菊甙 噢弄斯定 E-2-[(4-甲氧基苯基)亚甲基]苯并[b]呋喃-3-酮 6-羟基-2-[羟基-(4-羟基苯基)甲基]-1-苯并呋喃-3-酮 6,4''-二羟基橙酮 5-乙酰基-2-苯甲酰基-1-苯并呋喃-3-酮 3(2H)-苯并呋喃酮,4,6-二羟基-2-[(4-羟基苯基)亚甲基]-,(2Z)- 3',5'-二溴-2',4,4',6-四羟基橙酮 2-苯甲酰基-6-甲氧基-1-苯并呋喃-3-酮 2-苯甲酰基-5-甲基-1-苯并呋喃-3-酮 2-苯甲酰基-1-苯并呋喃-3(2H)-酮 2-苯甲酰-2-羟基-1-苯并呋喃-3-酮 2-氨基-6-氯-3-硝基吡啶 2-氨基-2-苄基-1-苯并呋喃-3-酮 2-[(Z)-(3,4-二羟基苯基)亚甲基]-6-羟基-7-甲氧基苯并呋喃-3(2H)-酮 2-[(4-羟基-3-甲氧基苯基)亚甲基]-7-甲氧基-1-苯并呋喃-3-酮 2-[(4-硝基苯基)亚甲基]-1-苯并呋喃-3-酮 2-[(4-甲氧基苯基)亚甲基]-5-甲基-1-苯并呋喃-3-酮 2-[(4-溴苯基)亚甲基]-1-苯并呋喃-3-酮 2-[(4-氟苯基)亚甲基]-6-羟基-1-苯并呋喃-3-酮 2-[(4-氟苯基)亚甲基]-6-甲氧基-1-苯并呋喃-3-酮 2-[(4-氟苯基)亚甲基]-5-甲基-1-苯并呋喃-3-酮 2-[(3-甲氧基苯基)亚甲基]-1-苯并呋喃-3-酮 2-[(3-甲基苯基)亚甲基]-1-苯并呋喃-3-酮 2-[(3,4-二甲氧基苯基)亚甲基]-1-苯并呋喃-3-酮 2-(4-甲氧基苯甲酰基)-1-苯并呋喃-3-酮 2-(3,4-二羟基苯甲酰)-2,4,6-三羟基-1-苯并呋喃-3-酮 2-(3,4-二羟基苯亚甲基)-6-羟基-3(2H)-苯并呋喃酮 2-(3,4-二羟基亚苄基)苯并呋喃-3(2H)-酮 1H-萘并[2,1-b]吡喃-2-甲腈,3-氨基-1-(2-氟苯基)- 1,1-二甲基铟烷-5,6-二醇 1,1,2-三甲基肼二盐酸 (Z)-4,6-二羟基橙酮 (7Z)-4-羟基-7-(苯基甲亚基)呋喃并[3,2-e][1,3]苯并二噁唑-8(7H)-酮 (2Z)-4,6-二羟基-2-[(3,4,5-三羟基苯基)亚甲基]-1-苯并呋喃-3-酮 (2E)-2-[(3-硝基苯基)亚甲基]-1-苯并呋喃-3-酮 2-((Z)-2,4-dimethoxy-benzylidene)-5-methyl-benzofuran-3-one (2Z)-5-[(dimethylamino)methyl]-6-hydroxy-2-(4-methoxybenzylidene)-7-methyl-1-benzofuran-3(2H)-one (2Z)-2-(2,4-dimethoxybenzylidene)-6-hydroxy-7-{[(2S)-2-(pyridin-3-yl)piperidin-1-yl]methyl}-1-benzofuran-3(2H)-one (2Z)-2-(3,4-dimethoxybenzylidene)-5-[(dimethylamino)-methyl]-6-hydroxy-7-methyl-1-benzofuran-3(2H)-one (Z)-2-(2,4-dimethoxybenzylidene)-6-hydroxybenzofuran-3(2H)-one (2Z)-6-hydroxy-2-(4-methoxybenzylidene)-7-{[(2S)-2-(pyridin-3-yl)piperidin-1-yl]methyl}-1-benzofuran-3(2H)-one (2Z)-6-hydroxy-7-{[(2S)-2-(pyridin-3-yl)piperidin-1-yl]-methyl}-2-(3,4,5-trimethoxybenzylidene)-1-benzofuran-3(2H)-one (2Z)-6-hydroxy-7-{[(2S)-2-(pyridin-3-yl)piperidin-1-yl]-methyl}-2-(2,3,4-trimethoxybenzylidene)-1-benzofuran-3(2H)-one (2Z)-2-(2,3-dimethoxybenzylidene)-6-hydroxy-7-{[(2S)-2-(pyridin-3-yl)piperidin-1-yl]methyl}-1-benzofuran-3(2H)-one (Z)-2-(2-hydroxy-3-methoxybenzylidene)benzofuran-3(2H)-one (Z)-2-(4-bromobenzylidene)-6-hydroxy-7-methylbenzofuran-3(2H)-one